20UG RP human GM-CSF

The University of Virginia awarded contract A207_PO-0450840 to Fisher Scientific Company LLC on June 19, 2026, for the procurement of laboratory reagents and biological materials. The primary deliverable under this contract is one unit of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine utilized in research and clinical applications. The product is designated for delivery to Angana Mainali at the University of Virginia, the contracting organization located in Virginia.

The total contract value is one hundred sixty-eight dollars, reflecting a single line item purchase at a unit price of one hundred sixty-eight dollars. As a specialized reagent procurement from an established life sciences supplier, this contract represents a routine acquisition of research materials by an academic medical institution. The award documentation does not specify a defined performance period or annual value structure, indicating this transaction functions as a straightforward purchase order rather than a multi-year service agreement.